PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-97.19%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-15.10%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
65.81%
EBIT growth above 1.5x RUN's 7.29%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
53.01%
Operating income growth above 1.5x RUN's 7.29%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
65.32%
Net income growth at 75-90% of RUN's 74.92%. Bill Ackman would press for improvements to catch or surpass competitor performance.
71.83%
EPS growth similar to RUN's 75.00%. Walter Schloss would assume both have parallel share structures and profit trends.
71.83%
Similar diluted EPS growth to RUN's 75.00%. Walter Schloss might see standard sector or cyclical influences on both firms.
-71.98%
Share reduction while RUN is at 0.65%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-72.01%
Reduced diluted shares while RUN is at 0.65%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
82.45%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
85.98%
FCF growth above 1.5x RUN's 11.66%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-96.39%
Negative 10Y revenue/share CAGR while RUN stands at 443.29%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-91.67%
Negative 5Y CAGR while RUN stands at 22.04%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-88.57%
Negative 3Y CAGR while RUN stands at 23.39%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-124.40%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
90.42%
Positive OCF/share growth while RUN is negative. John Neff might see a comparative advantage in operational cash viability.
57.28%
3Y OCF/share CAGR above 1.5x RUN's 30.51%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-136.70%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
69.14%
Positive 5Y CAGR while RUN is negative. John Neff might view this as a strong mid-term relative advantage.
30.87%
Positive short-term CAGR while RUN is negative. John Neff would see a clear advantage in near-term profit trajectory.
-118.50%
Negative equity/share CAGR over 10 years while RUN stands at 461.88%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
14.22%
Below 50% of RUN's 190.28%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-182.52%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.27%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-98.94%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-96.97%
Negative asset growth while RUN invests at 1.88%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-199.02%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-81.21%
We’re deleveraging while RUN stands at 4.13%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while RUN invests at 57.73%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-47.57%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.